← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2004Last known activity
Sep 28, 2023
Defunct as of Dec 31, 2010
Timeline
1990s
- Jan 1, 1992
NeuTec Pharma— Founded
2010s
- Dec 31, 2010
NeuTec Pharma— Defunct
Drugs by trial phase (25 distinct, 22 trials)
Phase 4 (17 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Bronchitis
- Bronchitis, Chronic
- Communicable Diseases
- Erectile Dysfunction
- Gastroesophageal Reflux
- Hypertension
- Infections
- Lung Diseases
- Lung Diseases, Obstructive
- Pneumonia
- Premature Birth
- Premature Ejaculation
- Pulmonary Disease, Chronic Obstructive
- Respiratory Aspiration
- Sinusitis
- Staphylococcal Infections
Recent trials (24)
- NCT06040424Lead sponsorPhase 3Sep 28, 2023
- NCT05890638Lead sponsorPhase 3Aug 25, 2023
- NCT04446637Lead sponsorPhase 3Sep 30, 2020
- NCT04457323Lead sponsorPhase 4Jul 15, 2020
- NCT04646109CollaboratorPhase 3May 11, 2020
- NCT03729258Lead sponsorPhase 3May 15, 2019
- NCT03355170Lead sponsorPhase 4Mar 1, 2018
- NCT03363503Lead sponsorPhase 4Jan 31, 2018
- NCT03395002Lead sponsorPhase 4Jan 31, 2018
- NCT03388853Lead sponsorPhase 4Jan 31, 2018
- NCT03400735Lead sponsorPhase 4Nov 1, 2017
- NCT03177746Lead sponsorPhase 4Jul 3, 2017
- NCT03037606Lead sponsorPhase 4Jul 1, 2017
- NCT02939495Lead sponsorPhase 4Oct 1, 2016
- NCT02988869Lead sponsorPhase 4Jul 1, 2016
Details
- Founded
- Istanbul, TR Jan 1, 1992
- Last known activity
- Sep 28, 2023
Notes
--- Pre-folding founded info: 1996-06-01 Manchester GB https://www.crunchbase.com/organization/neutec-pharma ---